Processa Pharmaceuticals, Inc. (PCSA)
NASDAQ: PCSA · Real-Time Price · USD
0.1948
+0.0063 (3.34%)
At close: Jul 3, 2025, 1:00 PM
0.1956
+0.0008 (0.41%)
After-hours: Jul 3, 2025, 4:55 PM EDT
Processa Pharmaceuticals Employees
Processa Pharmaceuticals had 10 employees as of December 31, 2024. The number of employees decreased by 3 or -23.08% compared to the previous year.
Employees
10
Change (1Y)
-3
Growth (1Y)
-23.08%
Revenue / Employee
n/a
Profits / Employee
-$1,195,814
Market Cap
5.10M
Employees Chart
Related Stocks
Company Name | Employees |
---|---|
UnitedHealth Group | 400,000 |
Johnson & Johnson | 138,100 |
Thermo Fisher Scientific | 125,000 |
Abbott Laboratories | 114,000 |
AstraZeneca | 94,300 |
Novo Nordisk | 77,349 |
Novartis AG | 75,883 |
Merck & Co. | 75,000 |
PCSA News
- 4 days ago - Processa Pharmaceuticals Provides Portfolio and Business Update - GlobeNewsWire
- 18 days ago - Processa Pharmaceuticals Announces Pricing of $7 Million Public Offering - GlobeNewsWire
- 18 days ago - Processa Pharmaceuticals Signs Binding Term Sheet Granting Intact Therapeutics Exclusive Option to License Phase 2 Gastroparesis Drug Candidate - GlobeNewsWire
- 22 days ago - Processa Pharmaceuticals to Engage Potential Partners and Investors at BIO International Convention 2025 - GlobeNewsWire
- 5 weeks ago - Processa Pharmaceuticals Announces Presentation and Publication of Three Abstracts at 2025 ASCO Annual Meeting - GlobeNewsWire
- 2 months ago - Processa Pharmaceuticals' Dr. David Young to Present at World Orphan Drug Congress USA 2025 - GlobeNewsWire
- 3 months ago - Processa Pharmaceuticals to Present at the MedInvest Biotech and Pharma Investor Conference - GlobeNewsWire
- 5 months ago - Processa Pharmaceuticals to Present at the 2025 BIO CEO & Investor Conference - GlobeNewsWire